Feature Articles

US Department of Energy (DOE) Undersecretary for Science Paul Dabbar, leaders from DOE's Brookhaven National Laboratory (Brookhaven Lab) and Thomas Jefferson National Accelerator Facility (Jefferson Lab), and elected officials from New York State and Virginia today commemorated the start of the Electron-Ion Collider project.

Joshua Carter is a co-founder and the CEO of Helix BioStructures, a contract research organization serving the pharmaceutical industry in early-phase drug discovery. Since starting Helix Biostructures in 2017, Carter has leveraged the fast-paced, industrial capabilities of NSLS-II to perform x-ray crystallography experiments for his high volume of clients. Through Carter's work at NSLS-II, in addition to other services his company provides, Helix Biostructures has helped the pharmaceutical industry develop and improve therapies for a variety of diseases.

When the COVID-19 pandemic hit , many students whose academic year had already been radically transformed also had to rejigger summer plans. Internships they'd expected to be in-person moved to all-virtual formats. For more than 30 students participating in virtual summer programs at Brookhaven Lab, that disruption presented an opportunity--a chance to engage in research related to the virus responsible for the upheaval.

High school summer students at Brookhaven Lab conduct computational studies, explore inhibitor drugs to disrupt COVID viral proteins that help infectious particles escape from cells.